Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: A multicentre study

European Urology

Volumn 61, Issue 1, 2012, Pages 185-192

  Cha, Eugene K ^a   Tirsar, Lenuta Ancuta ^b,c   Schwentner, Christian ^c   Christos, Paul J ^a   Mian, Christine ^d   Hennenlotter, Joerg ^c   Martini, Thomas ^d   Stenzl, Arnulf ^c   Pycha, Armin ^d   Shariat, Shahrokh F ^a   Schmitz Dräger, Bernd J ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Fürth and Urologie24 ^*  (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Cystoscopy; Decision curve analysis; Early detection of cancer; Hematuria; Immunocytology; Nomograms; Urinary bladder neoplasms

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HEMATURIA; HUMAN; IMMUNOCYTOLOGY; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOMOGRAM; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROBABILITY; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOPSY; DECISION SUPPORT TECHNIQUES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GERMANY; HEMATURIA; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; NOMOGRAMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS; UROTHELIUM; YOUNG ADULT;

EID: 82255174932     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.08.073     Document Type: Article

References (21)

1. G.D. Grossfeld, M.S. Litwin, and J.S. Wolf Jr. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up Urology 57 2001 604 610
2. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
3. E.K. Johnson, S. Daignault, Y. Zhang, and C.T. Lee Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72 2008 498 502 discussion 502-3
4. A.M. Nieder, Y. Lotan, and G.R. Nuss Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey Urol Oncol 28 2010 500 503
5. E.M. Messing, L. Teot, and H. Korman Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States J Urol 174 2005 1238 1241 (Pubitemid 41318690)
6. P.I. Karakiewicz, S. Benayoun, and C. Zippe Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder BJU Int 97 2006 997 1001
7. B.W.G. van Rhijn, H.G. van der Poel, and T.H. van der Kwast Urine markers for bladder cancer surveillance: a systematic review Eur Urol 47 2005 736 748 (Pubitemid 40745338)
8. C. Mian, K. Maier, and E. Comploj uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses Cancer 108 2006 60 65 (Pubitemid 43291246)
9. B.J. Schmitz-Dräger, B. Beiche, L.-A. Tirsar, C. Schmitz-Dräger, E. Bismarck, and T. Ebert Immunocytology in the assessment of patients with asymptomatic microhaematuria Eur Urol 51 2007 1582 1588 discussion 1588 (Pubitemid 46656312)
10. B.J. Schmitz-Drager, L.A. Tirsar, and C. Schmitz-Drager Immunocytology in the assessment of patients with asymptomatic hematuria World J Urol 26 2008 31 37
11. F.L. Greene American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual ed. 6 2002 Springer-Verlag New York
12. J.I. Epstein, M.B. Amin, V.R. Reuter, and F.K. Mostofi The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435 1448 (Pubitemid 28550639)
13. G. Sauter, F. Algaba, and M.B. Amin Noninvasive urothelial neoplasias: WHO classification of noninvasive papillary urothelial tumors J.N. Eble, G. Sauter, J.I. Epstein, World Health Organization classification of tumors: pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon p. 110-23
14. R. Montironi, A. Lopez-Beltran, M. Scarpelli, R. Mazzucchelli, and L. Cheng Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder Histopathology 53 2008 621 633 (Pubitemid 352768708)
15. B. Efron, and R. Tibshirani An introduction to the bootstrap 1993 Chapman & Hall New York
16. F.E. Harrell Jr. , K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
17. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574 (Pubitemid 44728772)
18. C. Pfister, D. Chautard, and M. Devonec Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study J Urol 169 2003 921 924 (Pubitemid 36188123)
19. P.L. Ross, C. Gerigk, and M. Gonen Comparisons of nomograms and urologists' predictions in prostate cancer Semin Urol Oncol 20 2002 82 88 (Pubitemid 34522545)
20. J. Walz, A. Gallina, and P. Perrotte Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer BJU Int 100 2007 1254 1258 (Pubitemid 350043902)
21. E.W. Steyerberg, F.E. Harrell Jr. , G.J. Borsboom, M.J. Eijkemans, Y. Vergouwe, and J.D. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781 (Pubitemid 32722180)